Ms. Manali Patwardhan Profile

Manali Patwardhan

SPIE Involvement:

Author

Publications (1)

Proceedings Article | 12 March 2024 Presentation + Paper

In vitro and in vivo evaluations of focused ultrasound induced immunomodulation in osteosarcoma

Alayna Hay, Lauren Ruger, Elliana Vickers, Manali Patwardhan, Sheryl Coutermarsh-Ott, Eli Vlaisavljevich, Joanne Tuohy

Proceedings Volume 12843, 1284303 (2024) https://doi.org/10.1117/12.3005917

KEYWORDS: Ablation, Tumors, In vitro testing, Diseases and disorders, Ultrasonography, Cell death, Bone

Read Abstract +

Osteosarcoma (OS) is the most common primary bone tumor in dogs and humans and is considered an immunologically “cold” tumor. OS exerts devastating impacts on patients and has not seen significant improvements in survival outcomes in decades, with resistant metastatic disease remaining a main cause of death. Innovative therapies are profoundly needed to improve treatment and outcomes in OS. Canine OS shares striking similarities with human OS but occurs at a greater prevalence, allowing the dog to serve as a valuable comparative oncology research model. Histotripsy, a novel non-thermal focused ultrasound technique, has potential to ablate the primary tumor and activate an immune response to mitigate metastatic disease, thus promising to turn OS into an immunologically “hot” tumor. The objective of this study was to evaluate the immunomodulatory effects of histotripsy after in vitro and in vivo OS ablation. We utilized in vitro cell culture models for mechanistic cell death and immune response evaluation. We delivered histotripsy in vivo to canine OS patients and assessed peripheral immune cells and the tumor microenvironment. Across species, after in vitro exposure of immune cells to histotripsy-ablated OS cells, we observed cellular phenotypic changes indicative of activation and upregulation of genes associated with immune cell chemotaxis, immune and inflammatory responses such as NK cell-mediated cytotoxicity. In vivo, histotripsy ablation led to significantly greater expression of activation markers CD80 and CD62L on circulating monocytes at 1 and 5 days post histotripsy (DPH) respectively. We observed significantly higher production of TGFβ in circulating monocytes at 3 DPH compared to baseline. On an independent patient basis, we observed a greater population of infiltrating CD5⁺CD4⁺ and CD5⁺CD8⁺ T-lymphocytes within the ablated compared to unablated regions of tumor, and noted intratumoral genetic signatures that indicate immune activation at 24 hours post histotripsy. Collectively our results suggest that histotripsy ablation of OS leads to immune activation.

View contact details

UPDATE YOUR PROFILE

Is this your profile? Update it now.

Sign into your SPIE.org account

Don’t have a profile and want one?

Create an account on SPIE.org

Keywords/Phrases

Search In:

Publication Years